Callio Therapeutics
PrivateLast Round
Series A
Mar 3, 2025
Total Funding Raised
$187M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Callio Therapeutics is a biotechnology company that develops next-generation, multi-payload antibody-drug conjugates (ADCs) for cancer therapy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Callio Therapeutics Comparables
Compare Callio Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Canwell Biotech Ltd. | 86% | |
| Eli Lilly and Company | 83% | |
| NetTargets | 78% | |
Callio Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 3, 2025 |
Key People
Founding team and executive leadership
Callio Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Omega Funds | Series A |
| SEEDS Capital | Series A |
| ClavystBio | Series A |
| EDBI | Series A |
| Norwest Venture Partners | Series A |
| Frazier Life Sciences | Series A |
| Novo Holdings | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 26, 2026
Monthly visitors increased 135% MoM, reaching 6.3K.
- May 16, 2026
Monthly visitors grew 2373% MoM, from 108 to 2.7K.
Callio Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Callio Therapeutics's valuation, stock price, and market status.